Search
analytical chemistry, bioinformatics and pharmaceutical sciences are developed and used in combination for drug optimization. Müller's work has been and continues to be supported by numerous international research [...] research, Müller takes a…
therefore, lies in making smart, purposeful data splits. In a new study, Prof Olga Kalinina, head of the Drug Bioinformatics group at HIPS, her PhD student Roman Joeres, and Prof David Blumenthal from FAU demonstrate [...] It can also automatically…
explains Dr. Jörg Haupenthal, a scientist in the team of Professor Anna Hirsch, head of the department “Drug Design and Optimization” at HIPS. Haupenthal is leading a project focused on developing new treatments [...] controlling P. aeruginosa…
killing algae or even human cells. Furanolides thus offer a promising basis for the development of new drugs. In addition to cyanobacteria and myxobacteria, natural sources of furanolides include some marine [...] were able to kill human cancer cells…
The production process was established by Prof. Marc Stadler, head of the department “Microbial Drugs” at HZI, while orally available formulations were developed in Bonn under Prof. Karl Wagner (supported [...] partners, the GHIT Fund mobilizes…
Pharmaceutical Research Saarland (HIPS). Her research focuses on developing smart materials for controlled drug delivery – systems that adapt to their environment and release active compounds precisely where and
targets for therapeutic interventions. Her research provides a promising foundation for developing drugs to treat age-related diseases, particularly in the field of neurodegeneration. With the support of
bacteria that are capable of producing natural products that could potentially be developed into new drugs for infectious diseases. At the same time, the researchers are working on methods to gain unprecedented
methods and biotechnological production systems are being developed to harness their potential for drug research. Neilan's many years of expertise in the genetics, biosynthesis, and metabolic elucidation
Resistant strains of Mycobacterium tuberculosis are particularly problematic, as many established drugs are becoming increasingly ineffective against them. However, a research team from the Helmholtz Institute